Cargando…
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
BACKGROUND: The serine/threonine kinase PIM1 has been implicated as an oncogene in various human cancers including lymphomas, gastric, colorectal and prostate carcinomas. In mouse models, Pim1 is known to cooperate with c-Myc to promote tumorigenicity. However, there has been limited analysis of the...
Autores principales: | Kim, Jongchan, Roh, Meejeon, Abdulkadir, Sarki A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886047/ https://www.ncbi.nlm.nih.gov/pubmed/20515470 http://dx.doi.org/10.1186/1471-2407-10-248 |
Ejemplares similares
-
Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011) -
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010) -
A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial Cells
por: Roh, Meejeon, et al.
Publicado: (2008) -
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
por: Kim, Jongchan, et al.
Publicado: (2009) -
A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53
por: Kim, Jongchan, et al.
Publicado: (2011)